Trial title: SFX-01 Treatment for Acute Respiratory Infections (STAR-Covid19)
COVID-19 is the illness caused by a new strain of coronavirus first identified in Wuhan city, China. It can cause a cough and/or a fever/high temperature. Generally, coronavirus can cause more severe symptoms in people with weakened immune systems, older people and those with long term conditions such as diabetes, cancer and chronic lung disease.
COVID-19 can affect the lungs and airways and cause difficulty breathing. There are no drugs at the moment which we know will definitely help people with COVID-19. Research is needed for therapies that will improve symptoms and survival of patients with COVID-19.
Professor James Chalmers and colleagues are running the STAR-COVID19 trial to see if a new drug, SFX-01, can help people with pneumonia or COVID-19. We think that SFX-01 may help people with pneumonia by reducing the amount of inflammation and damage in their lungs.
The trial is being Sponsored by the University of Dundee & NHS Tayside and is being managed by Tayside Clinical Trials Unit.
Please click on the link for more detailed Trial Information.